A new report on Crestor is raising safety concerns AGAIN

July 2005

A new report on Crestor is raising safety concerns AGAIN.

This analysis suggests a trend towards more cases of severe myopathy and a higher rate of proteinuria with Crestor.

The FDA looked at this data previously...and decided to leave Crestor on the market for now. They say the incidence of side effects with Crestor is similar to that of the other statins.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

pharmacogenomics to personalize drug therapy based on a person's genes
Heart Disease new form of Viagra called Revatio
Heart Disease A new report on Crestor is raising safety concerns AGAIN
Kidney Disease best way to measure kidney function
Dermatology recent headlines that suggest sunscreens cause cancer
Dermatology what works for poison ivy
Diabetes how to PREVENT type 2 diabetes
Diabetes Accidental changes in glucometer settings can cause some patients to misinterpret their blood glucose readings
Scientists are now taking omega-3 fatty acids more seriously
Infectious Diseases HIGHER doses of Bactrim or Septra for certain skin infections
Infectious Diseases a new IV antibiotic called Tygacil
Infectious Diseases Zostavax, a new vaccine for shingles
Supplements How much oral vitamin B12 is needed to treat B12 deficiency
Do patients at risk for anaphylaxis have to avoid beta-blockers
SSRIs seem to increase the risk of GI bleeding

A new report on Crestor is raising safety concerns AGAIN

Practical advice for a better career, with unlimited access to CE

Table of Contents